Effect of fenofibrate on the acquisition and reinstatement of ethanol-induced conditioned place preference in mice

سال انتشار: 1405
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 25

فایل این مقاله در 8 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_PRJMS-29-2_004

تاریخ نمایه سازی: 23 مهر 1405

چکیده مقاله:

Introduction: Fenofibrate is a ligand for peroxisome proliferator-activated receptors (PPARs) and increases catalase activity in the liver. Hence, it could be a potential candidate to mitigate alcohol dependence. Here, we tested whether fenofibrate attenuates alcohol dependency in a mouse model.Methods: Conditioned place preference (CPP) was induced in male mice. Three groups were used: ۱. Saline-Ethanol / Saline-Saline; ۲. Saline-Ethanol / Fenofibrate -Ethanol ; ۳. Saline-Saline/ Fenofibrate -Saline. CPP was defined as significantly more time spent on the drug-paired floor (grid) versus the saline-paired floor (hole). After extinction, reinstatement was triggered by a priming dose of ethanol, with or without fenofibrate pretreatment.Results: Ethanol (۲ g/kg) significantly increased time spent on the grid floor compared to the hole floor (P < ۰.۰۱), indicating successful CPP. Fenofibrate alone did not induce CPP (P > ۰.۰۵). In the fenofibrate + ethanol group, no significant difference was observed between grid and hole times (P > ۰.۰۵), indicating inhibition of CPP acquisition. During extinction, place conditioning was absent in all groups. Pretreatment with fenofibrate significantly reduced reinstatement of ethanol-induced CPP (P < ۰.۰۵).Conclusion: Fenofibrate reversed the establishment of ethanol-induced CPP and attenuated its reinstatement in mice. These findings suggest that fenofibrate may be a potential candidate for further research on alcohol dependence, though additional investigations are needed.

نویسندگان

KOBRA SHIRANI

Unit ۶.No ۱,North golestan Mahestan shahrak gharb

Faezeh Vahdati Hassani

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Maliheh Ezati

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Ali Roohbakhsh

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran

Gholamreza Karimi

Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran. Pharmaceutical Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran.